Medincell: Raises €43 Million to Boost Pharmaceutical Innovations
Deal News | Feb 25, 2025 | Goodwin
Medincell, a French pharmaceutical technology company specializing in long-acting injectable products, has successfully concluded a capital increase amounting to approximately €43 million. This financial milestone was achieved through a strategic offering targeting institutional investors via private placement and retail investors through France's PrimaryBid platform. Goodwin, a reputable advisory firm, spearheaded the guidance on this transaction, advising Jefferies, Evercore, Bryan Garnier & Co., and Truist. The funds raised will empower Medincell to extend its proprietary BEPO technology into new molecules and high-value therapeutic areas, positioning the company for further innovation and potential integration of complementary technologies. A team from Goodwin, led by Guilhem Richard and Ben Marsh, provided adept oversight on French and US legal aspects, respectively.
Sectors
- Pharmaceuticals
- Financial Services
Geography
- France – The main company, Medincell, is based in France, and the public offering was specifically in the French market.
- United States – Legal advice was managed by Goodwin with a team specializing in US law aspects.
Industry
- Pharmaceuticals – The article involves a pharmaceutical technology company, Medincell, which is developing injectable products.
- Financial Services – Involvement of financial services through a capital increase transaction managed by advisors and banks.
Financials
- €43 Million – Total amount raised by Medincell through the capital increase.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Medincell | Target Company | Company | A French pharmaceutical technology company focusing on long-acting injectable products. |
| Goodwin | Legal Advisor | Company | Provided legal guidance for the capital increase transaction involving Medincell. |
| Jefferies | Financial Advisor/Broker | Company | Involved in advising the capital increase for Medincell. |
| Evercore | Financial Advisor/Broker | Company | Involved in advising the capital increase for Medincell. |
| Bryan Garnier & Co. | Financial Advisor/Broker | Company | Involved in advising the capital increase for Medincell. |
| Truist | Financial Advisor/Broker | Company | Involved in advising the capital increase for Medincell. |
| Guilhem Richard | Legal Advisor - French Law | People | Led the French law team from Goodwin advising on the capital increase. |
| Ben Marsh | Legal Advisor - US Law | People | Led the US law team from Goodwin advising on the capital increase. |